Related references
Note: Only part of the references are listed.Current status of drug screening and disease modelling in human pluripotent stem cells
Divya Rajamohan et al.
BIOESSAYS (2013)
Extracellular Matrix Promotes Highly Efficient Cardiac Differentiation of Human Pluripotent Stem Cells The Matrix Sandwich Method
Jianhua Zhang et al.
CIRCULATION RESEARCH (2012)
Cardiomyocytes derived from human pluripotent stem cells for drug screening
Naama Zeevi-Levin et al.
PHARMACOLOGY & THERAPEUTICS (2012)
High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents
Junyi Ma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Resident cardiac progenitor cells: At the heart of regeneration
Sveva Bollini et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
STEM CELLS The dark side of induced pluripotency
Martin F. Pera
NATURE (2011)
Assaying cardiac biomarkers for toxicity testing using biosensing and cardiomyocytes derived from human embryonic stem cells
Henrik Andersson et al.
JOURNAL OF BIOTECHNOLOGY (2010)
Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes
Stefan R. Braam et al.
STEM CELL RESEARCH (2010)
The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes
Shengde Peng et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2010)
Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells
Limor Zwi et al.
CIRCULATION (2009)
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Jianhua Zhang et al.
CIRCULATION RESEARCH (2009)
Improvement of cardiac efficacy and safety models in drug discovery by the use of stem cell-derived cardiomyocytes
Malin K. B. Jonsson et al.
EXPERT OPINION ON DRUG DISCOVERY (2009)
2008 FDA drug approvals
Bethan Hughes
NATURE REVIEWS DRUG DISCOVERY (2009)
Stem cells and drug discovery: The beginning of a new era?
Lee L. Rubin
CELL (2008)
Human cardiovascular progenitor cells develop from a KDR plus embryonic-stem-cell-derived population
Lei Yang et al.
NATURE (2008)
Induced pluripotent stem cell lines derived from human somatic cells
Junying Yu et al.
SCIENCE (2007)
Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts
Michael A. Laflamme et al.
NATURE BIOTECHNOLOGY (2007)
Embryonic stem cells as a source of models for drug discovery
Colin W. Pouton et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
RS Bresalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
QT-Screen:: High-throughput cardiac safety pharmacology by extracellular electrophysiology on primary cardiac myocytes
T Meyer et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2004)
Human embryonic stem cells develop into multiple types of cardiac myocytes - Action potential characterization
JQ He et al.
CIRCULATION RESEARCH (2003)
Share Paper
